Evidence mapPaperPMID 37424866Full record

ArticleFrontiers in endocrinology2023

Is increased myocardial triglyceride content associated with early changes in left ventricular function? A

Astrid Soghomonian, Anne Dutour, Nadjia Kachenoura, Franck Thuny, Adele Lasbleiz, Patricia Ancel, Robin Cristofari, Elisabeth Jouve, Umberto Simeoni, Frank Kober and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Society for Cardiovascular Magnetic Resonance reference values ("normal values") in cardiovascular magnetic resonance: 2025 update.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2025
    Guideline
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Human cardiac metabolism.Cell metabolism · 2024
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Astrid SoghomonianAix-Marseille Université, INSERM, INRAE, C2VN, Marseille, France.
Anne DutourAix-Marseille Université, INSERM, INRAE, C2VN, Marseille, France.
Nadjia KachenouraSorbonne Université, INSERM, CNRS, Laboratoire d'Imagerie Biomédicale, Paris, France.
Franck ThunyAix-Marseille Université, INSERM, INRAE, C2VN, Marseille, France.
Adele LasbleizAix-Marseille Université, INSERM, INRAE, C2VN, Marseille, France.
Patricia AncelAix-Marseille Université, INSERM, INRAE, C2VN, Marseille, France.
Robin CristofariDepartment of Biology, University of Turku, Turku, Finland.
Elisabeth JouveUPCET, Clinical Pharmacology, Assistance-Publique Hôpitaux de Marseille, Marseille, France.
Umberto SimeoniDivision of Pediatrics & DOHaD Laboratory, CHUV University Hospital and University of Lausanne, Lausanne, Switzerland.
Frank KoberAix-Marseille Université, CNRS, CRMBM, Marseille, France.
Monique BernardAix-Marseille Université, CNRS, CRMBM, Marseille, France.
Bénédicte GaboritAix-Marseille Université, INSERM, INRAE, C2VN, Marseille, France.
Inserm · FRCentre National de la Recherche Scientifique · FRAssistance Publique Hôpitaux de Marseille · FRUniversity of Lausanne · CHUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Type 2 diabetes (T2D) and obesity induce left ventricular (LV) dysfunction. The underlying pathophysiological mechanisms remain unclear, but myocardial triglyceride content (MTGC) could be involved. Objectives: This study aimed to determine which clinical and biological factors are associated with increased MTGC and to establish whether MTGC is associated with early changes in LV function. Methods: A retrospective study was conducted using five previous prospective cohorts, leading to 338 subjects studied, including 208 well-phenotyped healthy volunteers and 130 subjects living with T2D and/or obesity. All the subjects underwent proton magnetic resonance spectroscopy and feature tracking cardiac magnetic resonance imaging to measure myocardial strain. Results: MTGC content increased with age, body mass index (BMI), waist circumference, T2D, obesity, hypertension, and dyslipidemia, but the only independent correlate found in multivariate analysis was BMI (p=0.01; R²=0.20). MTGC was correlated to LV diastolic dysfunction, notably with the global peak early diastolic circumferential strain rate (r=-0.17, p=0.003), the global peak late diastolic circumferential strain rate (r=0.40, p<0.0001) and global peak late diastolic longitudinal strain rate (r=0.24, p<0.0001). MTGC was also correlated to systolic dysfunction Conclusions: Predicting MTGC remains a challenge in routine clinical practice, as only BMI independently correlates with increased MTGC. MTGC may play a role in LV dysfunction but does not appear to be involved in the development of subclinical strain abnormalities.

Indexed as

Diabetes Mellitus, Type 2Ventricular Dysfunction, LeftHumansMagnetic Resonance ImagingObesityProton Magnetic Resonance SpectroscopyRetrospective StudiesTriglyceridesVentricular Function, LeftTriglyceridescardiac magnetic resonance imagingfeature-trackingleft ventricular functionmyocardial strainmyocardial triglyceride contentobesitytype 2 diabetes

Identifiers

PMID37424866
PMCPMC10323751
OpenAlexW4381800431

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.